Clinical Trials Logo

Clinical Trial Summary

There are more than 100 million patients who develop scar formation caused by various factors, such as post-inflammatory acne and trauma (1). They often have physical, aesthetic, psychological, and social barriers. Scar tissue is naturally a stage of wound healing. Abnormal wound healing produces a spectrum of scar tissue types such as atrophic, hypertrophic, and keloid scars (2). Atrophic scars are dermal depressions, which are commonly caused by the destruction of collagen following inflammatory process. This permanent disfiguring sequelae correlates with the duration of pathology, severity of lesion, and delay in therapy (3). Treatment of atrophic acne scars remains a therapeutic challenge, yet there is no standard option as the most effective treatment (4). A range of possible options has been investigated including surgical techniques (subcision, non-ablative laser treatment, resurfacing techniques (ablative laser treatment, dermabrasion), and injection or dermal fillers or fat, and a combination of two or more modalities (5). Ultrasound is a unique non-invasive and non-radiating medical imaging tool in the investigation of dermatological diseases by providing detailed anatomic and physiologic data of skin lesions and deeper soft tissue changes. Lesion size in three dimensions-lengths, width, and depth, morphology, the detailed anatomic information provided by sonography is useful to assessment of effect of different types of treatment modality to improve atrophic scar and avoid invasive assessment tools as punch biopsy for histopathological examination (6)


Clinical Trial Description

atrophic scar mangment ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06298591
Study type Interventional
Source Assiut University
Contact
Status Not yet recruiting
Phase N/A
Start date March 15, 2024
Completion date March 15, 2027

See also
  Status Clinical Trial Phase
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Recruiting NCT05936437 - Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment N/A
Active, not recruiting NCT04519515 - Vollure for the Correction of Atrophic Facial Scarring N/A
Completed NCT03264573 - Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars N/A
Not yet recruiting NCT05695807 - Carboxytherapy in the Treatment of Atrophic Scars N/A
Recruiting NCT06210919 - Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars Phase 1
Completed NCT05686603 - Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar N/A